【摘要】 目的探析小儿肺炎支原体肺炎采取阿奇霉素联合布地奈德混悬液雾化吸入治疗的临床效果。方法随机选取该院2012年1月—2014年12月收治的100例小儿肺炎支原体肺炎患儿,将其随机分为治疗组和对照组,各50例,治疗组给予阿奇霉素联合布地奈德混悬液雾化吸入,对照组采取阿奇霉素联合盐酸氨溴索治疗,比较两组治疗效果、咳嗽、喘憋缓解时间等。结果治疗组总有效率92.0%与对照组76.0%比较差异有统计学意义,P<0.05;治疗组咳嗽、喘憋缓解时间、啰音消失时间及住院时间分别为(6.52±1.53)d、(2.42±1.11)d、(4.19±1.56)d、(7.03±1.55)d,与对照组比较差异有统计学意义,P<0.05。结论小儿肺炎支原体肺炎采取阿奇霉素联合布地奈德混悬液雾化吸入治疗,临床效果确切,值得临床推广。更多还原

【Abstract】 Objective Analysis of Mycoplasma pneumoniae pneumonia take azithromycin budesonide inhalation therapy clinical effect. Methods Random selection our hospital in January 2012 to December 2014 children admitted 100 cases of Mycoplasma pneumoniae pneumonia were randomly divided into treatment group and control group, 50 patients, the treatment group received azithromycin budesonide fog inhalation of the control group taking azithromycin ambroxol therapy,therapeutic effects were compared, coughing, wheezing remission time.Results Treatment group, the total efficiency of92.0% and 76.0% in control group, the difference was significant, P <0.05; treatment group cough, wheezing remission time,rale disappearing time and hospital stay were(6.52±1.53) d,(2.42±1.11) d,(4.19±1.56) d,(7.03±1.55) d, significant differences compared with control group, P <0.05.Conclusion Mycoplasma pneumoniae pneumonia in children taking azithromycin budesonide inhalation therapy, the clinical results, worthy of promotion.更多还原